The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

11451–11475 of 17987

  • ModerateFDA (Drugs)·D-0120-2017·2016-11-09

    Par Pharmaceutical Recalls Subpotent Gildess 1/20 Oral Contraceptive Tablets

    Par Pharmaceutical is recalling Gildess 1/20 tablets because they contain subpotent levels of ethinyl estradiol. The recall covers 393,981 tablets distributed nationwide and in Puerto Rico.

    Product
    Gildess 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0,02 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7607-48) and (b) 6 blisters (NDC 0603-7607-15), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0123-2017·2016-11-09

    Par Pharmaceutical Recalls Subpotent Gildess 24 FE 1.5/30 Oral Contraceptives

    Par Pharmaceutical is recalling Gildess 24 FE 1.5/30 oral contraceptives because the ethinyl estradiol component is subpotent. The recall covers 44,127 tablets distributed nationwide and in Puerto Rico.

    Product
    Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, (a) 3 blisters (NDC 0603-7610-49), and (b) 6 blisters (NDC 0603-7610-17), Rx only, Manufactured in Canada By: Patheon, Inc.…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0117-2017·2016-11-09

    Taro Recalls Desoximetasone Cream Due to Stability Test Failures

    Taro Pharmaceuticals is recalling specific lots of Desoximetasone Cream 0.05% because they failed stability specifications for homogeneity.

    Product
    DESOXIMETASONE — DESOXIMETASONE (DESOXIMETASONE)
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0121-2017·2016-11-09

    Par Pharmaceutical Recalls Subpotent Gildess FE 1/20 Oral Contraceptive Tablets

    Par Pharmaceutical is recalling Gildess FE 1/20 tablets because the ethinyl estradiol component is subpotent. The recall covers 822,009 tablets distributed nationwide and in Puerto Rico.

    Product
    Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, 6 blisters (NDC 0603-7609-17), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST…
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0118-2017·2016-11-09

    Actavis Recalls Ramipril Capsules Due to Incorrect Expiration Date Labeling

    Actavis is recalling 15,984 bottles of Ramipril Capsules because they were labeled with an incorrect expiration date of 03/18 instead of 09/17.

    Product
    Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0122-2017·2016-11-09

    Par Pharmaceutical Recalls Subpotent Gildess FE 1.5/30 Oral Contraceptive Tablets

    Par Pharmaceutical is recalling Gildess FE 1.5/30 tablets because they may contain subpotent levels of ethinyl estradiol.

    Product
    Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate tablets, USP 75 mg), 6 blisters (28 count), NDC 0603-7608-17, Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST…
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0113-2017·2016-11-02

    Persantine Tablets Recalled Due to Presence of Foreign 50 mg Tablets

    Boehringer Ingelheim is recalling 2,562 bottles of 75 mg Persantine tablets because 50 mg tablets were found inside the bottles.

    Product
    Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0114-2017·2016-11-02

    Boehringer Ingelheim Recalls Dipyridamole Tablets Due to Foreign Tablet Presence

    Boehringer Ingelheim is recalling 6,400 bottles of 75 mg Dipyridamole tablets because 50 mg Persantine tablets were found inside the bottles.

    Product
    DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-0436-25
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0115-2017·2016-11-02

    Invokamet Recalled for Incorrect or Missing Package Insert Labeling

    Janssen Ortho L.L.C. is recalling Invokamet tablets because Xarelto prescribing information outserts may be affixed to the bottles instead of the correct Invokamet inserts.

    Product
    INVOKAMET — INVOKAMET (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0104-2017·2016-10-26

    Dietary Supplement Recalled for Undeclared Sildenafil and Analogs

    SOS Telecom Inc. is recalling Super Samurai-X dietary supplements because FDA testing found undeclared sildenafil and/or its analogs.

    Product
    Super Samurai-X , 1000 mg, 1 capsule per pack , 24 single packs per box.
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-0102-2017·2016-10-26

    FDA Recalls Ninja-X Dietary Supplement for Undeclared Sildenafil

    SOS Telecom Inc. is recalling Ninja-X dietary supplements because FDA analysis found undeclared sildenafil or its analogs. The product was marketed without an approved NDA or ANDA.

    Product
    Ninja-X, 4200 mg, 1 capsule per pack, 24 single packs per box.
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-0101-2017·2016-10-26

    Tiger-X Dietary Supplement Recalled for Undeclared Sildenafil

    SOS Telecom Inc. is recalling Tiger-X dietary supplements because FDA testing found undeclared sildenafil or analogs. The product was marketed without an approved NDA or ANDA.

    Product
    Tiger-X, 1200 mg, 1 capsule per pack , 24 single packs per box
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-0103-2017·2016-10-26

    Ginseng Power-X Recalled for Undeclared Sildenafil

    SOS Telecom Inc. is recalling Ginseng Power-X capsules because FDA testing found undeclared sildenafil or analogs.

    Product
    Ginseng Power-X , 1800 mg, 1 capsule per pack , 24 single packs per box.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0106-2017·2016-10-26

    Dream Body Extreme Gold Recalled for Undeclared Sibutramine

    Dream Body Weight Loss is recalling Dream Body Extreme Gold capsules because they contain undeclared sibutramine and were marketed without FDA approval.

    Product
    Dream Body Extreme Gold 800 mg 30 capsules in a plastic screw on top bottle
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0107-2017·2016-10-26

    Dream Body Weight Loss Capsules Recalled for Undeclared Sibutramine

    Dream Body Weight Loss is recalling Dream Body 450 mg capsules because they contain undeclared sibutramine and were marketed without FDA approval.

    Product
    Dream Body 450 mg 30 capsules in a plastic screw on top bottle
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0108-2017·2016-10-26

    Dream Body Advanced capsules recalled for undeclared sibutramine

    Dream Body Advanced 400 mg capsules are being recalled because they contain undeclared sibutramine and were marketed without an approved NDA/ANDA.

    Product
    Dream Body Advanced 400 mg 30 capsules in brown foil packets.
    Category
    Drug
    Distribution
    0 states
  • HighFDA (Drugs)·D-0112-2017·2016-10-26

    Supernus Recalls Trokendi XR Capsules Due to Assay Failure

    Supernus Pharmaceuticals is recalling Trokendi XR (topiramate) capsules because they failed to meet assay specifications.

    Product
    TROKENDI XR — TROKENDI XR (TOPIRAMATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0105-2017·2016-10-26

    Arbor Pharmaceuticals Recalls Cetylev Tablets Due to Defective Blister Packaging

    Arbor Pharmaceuticals is recalling Cetylev (acetylcysteine) effervescent tablets because incomplete seals on the blister packaging allow moisture to enter, causing the tablets to swell.

    Product
    Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20 tablets per carton (ten 2 count blister packs), Distributed by Arbor Pharmaceuticals, LLC Atlanta, GA 30328, NDC 24338-700-10.
    Category
    Drug
    Distribution
    14 states
  • LowFDA (Drugs)·D-0111-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling specific lots of Paricalcitol Capsules because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7658-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0110-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling 5,556 bottles of Paricalcitol Capsules because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 2 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7657-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0109-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling 32,015 bottles of Paricalcitol Capsules, 1 mcg, because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7656-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0020-2017·2016-10-19

    Oasis Dietary Supplement Capsules Recalled for Unapproved Active Ingredients

    Bee Xtreme LLC is recalling Oasis Dietary Supplement Capsules because FDA analysis found the products contain sibutramine and phenolphthalein without an approved NDA or ANDA.

    Product
    Oasis Dietary Supplement Capsules, 500 mg, 45 count bottles, Manufactured for Timeless Solutions, 1810 E Sahara Ave #100, Las Vegas, Nevada 89104, distributed by BeeXtreme LLC, Punxsutawney PA
    Category
    Drug
    Distribution
    0 states
  • CriticalFDA (Drugs)·D-0019-2017·2016-10-19

    La' Trim Plus Capsules Recalled for Unapproved Active Ingredients

    Bee Xtreme LLC is recalling La' Trim Plus dietary supplements because FDA analysis found unapproved drugs sibutramine and phenolphthalein.

    Product
    La' Trim Plus Dietary Supplement Capsules, 350 mg, 60 count bottles, Manufactured for Timeless Solutions, 1810 E Sahara Ave #100, Las Vegas, Nevada 89104, distributed by BeeXtreme LLC, Punxsutawney PA
    Category
    Drug
    Distribution
    0 states
  • CriticalFDA (Drugs)·D-0094-2017·2016-10-19

    B. Braun Recalls 5% Dextrose Injection Due to Fungal Contamination

    B. Braun Medical Inc. is recalling 57,408 units of 5% Dextrose Injection USP due to non-sterility caused by fungal contamination from leaking containers.

    Product
    5% Dextrose Injection USP, 100mL in a 150 mL PAB container, Rx only, B. Braun Medical Inc. Irvine, CA 92614-5895 USA, NDC 00264-1510-32
    Category
    Drug
    Distribution
    Distributed nationwide